Track Chonluten in Peptimes™
Chonluten is a peptide of three amino acids: Glu-Asp-Gly (glutamyl-aspartyl-glycine). The US National Library of Medicine's MeSH vocabulary lists this tripeptide. (Source: NLM MeSH.)
Is Chonluten FDA-approved?
No. Chonluten isn't FDA-approved: Drugs@FDA lists no application with Chonluten (Glu-Asp-Gly) as an active ingredient.
Chonluten
Also: EDG peptide, Glu-Asp-Gly, glutamyl-aspartyl-glycine
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- OralSublingual
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In animals or the lab
In a human immune-cell line in the lab, Chonluten lowered the release of the inflammatory signal TNF from cells exposed to bacterial material. A cell study, with Khavinson, whose group developed it, among the authors.
Source: PMID 35408963, checked 1 Nov 2026
How to track it in Peptimes
Add Chonluten in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: oral or sublingual. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel. Neither route has an injection site to record.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Chonluten or any other compound.
More sources
- Avolio and colleagues, Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line (2022), read 1 Nov 2026: names Chonluten as the tripeptide Glu-Asp-Gly.
- NLM, MeSH, glutamyl-aspartyl-glycine, checked 1 Nov 2026: the tripeptide, with the entry terms Glu-Asp-Gly and T-34 tripeptide.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists Chonluten or Glu-Asp-Gly as an active ingredient.
- NIH, ClinicalTrials.gov, studies of Chonluten, checked 1 Nov 2026: no registered study.